NCT00453414View on ClinicalTrials.gov

Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Iloprost Inhalation Solution (Ventavis)

Trial Locations (2)

10032

Columbia University Medical Center, New York

80218

The Children's Hospital, Denver

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT00453414 - Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter